123 related articles for article (PubMed ID: 36857429)
1. [Quantitative assessment of breast cancer resistance protein during pregnancy in rabbits].
Popova NM; Slepnev AA; Abalenikhina YV; Shchulkin AV; Rokunov ED; Yakusheva EN
Biomed Khim; 2023 Feb; 69(1):72-77. PubMed ID: 36857429
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor-mediated regulation of the BCRP/
Gorczyca L; Aleksunes LM
Expert Opin Drug Metab Toxicol; 2020 Mar; 16(3):239-253. PubMed ID: 32077332
[No Abstract] [Full Text] [Related]
3. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
[TBL] [Abstract][Full Text] [Related]
4. TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR.
Bhagyaraj E; Ahuja N; Kumar S; Tiwari D; Gupta S; Nanduri R; Gupta P
Cell Cycle; 2019 Dec; 18(24):3589-3602. PubMed ID: 31739702
[TBL] [Abstract][Full Text] [Related]
5. Chicken xenobiotic receptor upregulates the BCRP/ABCG2 transporter.
Xu Z; Li M; Lu W; Wang L; Zhang Y
Poult Sci; 2023 Jan; 102(1):102278. PubMed ID: 36402040
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer.
Wu X; Zhang X; Zhang H; Su P; Li W; Li L; Wang Y; Liu W; Gao P; Zhou G
Cancer Sci; 2012 May; 103(5):959-67. PubMed ID: 22348324
[TBL] [Abstract][Full Text] [Related]
7. Interindividual Regulation of the Breast Cancer Resistance Protein/
Bircsak KM; Moscovitz JE; Wen X; Archer F; Yuen PYS; Mohammed M; Memon N; Weinberger BI; Saba LM; Vetrano AM; Aleksunes LM
Drug Metab Dispos; 2018 May; 46(5):619-627. PubMed ID: 29386232
[TBL] [Abstract][Full Text] [Related]
8. Progesterone negatively regulates BCRP in progesterone receptor-positive human breast cancer cells.
Wu X; Zhang X; Sun L; Zhang H; Li L; Wang X; Li W; Su P; Hu J; Gao P; Zhou G
Cell Physiol Biochem; 2013; 32(2):344-54. PubMed ID: 23988382
[TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.
Wang H; Lee EW; Zhou L; Leung PC; Ross DD; Unadkat JD; Mao Q
Mol Pharmacol; 2008 Mar; 73(3):845-54. PubMed ID: 18042733
[TBL] [Abstract][Full Text] [Related]
10. Expression of BCRP/ABCG2 Protein in Invasive Breast Cancer and Response to Neoadjuvant Chemotherapy.
Zhang YS; Yang C; Han L; Liu L; Liu YJ
Oncol Res Treat; 2022; 45(3):94-101. PubMed ID: 34775385
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E
Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.
Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG
J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980
[TBL] [Abstract][Full Text] [Related]
13. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.
Wang H; Zhou L; Gupta A; Vethanayagam RR; Zhang Y; Unadkat JD; Mao Q
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E798-807. PubMed ID: 16352672
[TBL] [Abstract][Full Text] [Related]
14. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
15. Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies.
Sun Z; Zhao Z; Li G; Dong S; Huang Z; Ye L; Liang H; Qu J; Ai X; Zhang W; Chen X
Tumori; 2010; 96(1):90-6. PubMed ID: 20437864
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Placental Breast Cancer Resistance Protein by HDAC1 in Mice: Implications for Optimization of Pharmacotherapy During Pregnancy.
Wang C; Ma D; Hua Y; Duan H
Reprod Sci; 2021 Dec; 28(12):3540-3546. PubMed ID: 34668144
[TBL] [Abstract][Full Text] [Related]
17. Regional expression of the BCRP/ABCG2 transporter in term human placentas.
Memon N; Bircsak KM; Archer F; Gibson CJ; Ohman-Strickland P; Weinberger BI; Parast MM; Vetrano AM; Aleksunes LM
Reprod Toxicol; 2014 Jan; 43():72-77. PubMed ID: 24269555
[TBL] [Abstract][Full Text] [Related]
18. The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.
Rigalli JP; Scholz PN; Tocchetti GN; Ruiz ML; Weiss J
Eur J Nutr; 2019 Feb; 58(1):139-150. PubMed ID: 29101532
[TBL] [Abstract][Full Text] [Related]
19. Placental BCRP/ABCG2 Transporter Prevents Fetal Exposure to the Estrogenic Mycotoxin Zearalenone.
Szilagyi JT; Gorczyca L; Brinker A; Buckley B; Laskin JD; Aleksunes LM
Toxicol Sci; 2019 Apr; 168(2):394-404. PubMed ID: 30576553
[TBL] [Abstract][Full Text] [Related]
20. Valproic Acid-Induced Upregulation of Multidrug Efflux Transporter ABCG2/BCRP via PPAR
Kukal S; Bora S; Kanojia N; Singh P; Paul PR; Rawat C; Sagar S; Bhatraju NK; Grewal GK; Singh A; Kukreti S; Satyamoorthy K; Kukreti R
Mol Pharmacol; 2023 Mar; 103(3):145-157. PubMed ID: 36414374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]